Search

everythinglearnresearchcommunity

for

Search:↓

Many COVID-19 patients experience temporary hair loss after infection, not linked to infection severity or treatment.

The document concludes that periocular hair disorders have various causes and treatments, and proper evaluation by specialists is important for management and prognosis.

Sorafenib causes skin reactions by increasing the number and activity of skin mast cells.

The document concludes that new treatments are needed to better manage acne and reduce side effects related to current therapies.

The document concluded that various dermatological treatments have different effectiveness and side effects, with some causing irritation, allergic reactions, or systemic effects.

9-cis-retinoic acid showed some effectiveness in treating AIDS-related Kaposi sarcoma but had significant side effects at higher doses.

COVID-19 infection can significantly cause temporary hair loss.

Older patients with advanced kidney cancer can be managed with a drug called Sunitinib.

Many people in Saudi Arabia experienced hair loss after COVID-19, especially women, those treated with antivirals, and those with a history of hair shedding.

Severe COVID-19 may cause hair loss, and doctors recommend supplements and topical treatments to manage it.

Balancing treatment effectiveness with side effects is crucial for relapsed follicular non-Hodgkin's lymphoma, especially in older patients.

Low dose oral minoxidil helps regrow hair in permanent chemotherapy-induced alopecia.

Current treatments for hair loss from chemotherapy are limited, but new methods are being researched.

Docetaxel often causes hair loss, with limited effective treatments and no cure for permanent hair loss.

ALA-PDT is effective and safe for chronic X-ray dermatitis, providing complete or partial remission.

A man lost all his hair after stopping hepatitis C treatment and it didn't grow back.

A man lost all his hair permanently after hepatitis C treatment, a side effect not seen before.

Some patients may experience temporary total hair loss from hepatitis C treatment with PEG-interferon and ribavirin.

A woman's total hair loss from hepatitis C treatment grew back after stopping the medication.

Hepatitis C virus can cause skin diseases and dermatologists play a crucial role in identifying these conditions.

Half of the patients treated with a specific drug for skin cancer experienced hair loss not related to the drug's dosage.

Using systemic drugs as creams for skin conditions shows promise, but more research is needed to confirm their effectiveness and safety.

Recombinant cytokine therapy can cause skin reactions ranging from mild to severe.

Chemotherapy and cytokine therapy can cause various skin reactions, including hair loss and hypersensitivity.

Finasteride increases hair density in female androgenetic alopecia, but individual results may vary.

Alopecia Areata is an autoimmune condition causing hair loss with no cure and treatments that often don't work well.

CCT128930 is a promising new drug that effectively targets and inhibits a cancer-related protein, showing potential for cancer treatment.

Repurposing existing drugs for COVID-19 shows promise but requires more research to confirm effectiveness.

Shrinking skin cancer increases the chance of cancer in nearby lymph nodes.

Freezing gamma-irradiated amniotic fluid may help hair growth and speed up the growth phase.